Upcoming Events

  • Most of our events take place in the McKusick Conference Room at Mission Hall, also known as the Global Health & Clinical Sciences Building on Mission Bay Campus, unless otherwise noted. [Directions to CAPS]
  • RSVP to Rochelle Blanco if you would like to attend. You will need to check in at the security desk upon arrival. Mention “Town Hall” at the security desk to expedite entry approval.

Friday, February 27th, 2015

CAPS Town Hall Presents Art Reingold, MD — Vaccines, Vaccination Policy, and Vaccine Hesitancy (12:00pm – 1:00pm)

Through the widespread use of vaccines, many countries have had great success eliminating or controlling infectious diseases that previously were the cause of substantial morbidity and mortality. The near to complete disappearance of several vaccine-preventable diseases has led to complacency in the community (and among some health care providers) which, combined with unwarranted fears concerning the safety of vaccines, has led to growing levels of “vaccine hesitancy” and even outright refusal of some vaccines.  The resulting pockets of susceptibility increase the likelihood of outbreaks and sustained transmission when such infections are introduced by travelers. While balancing the rights of the individual and the rights of the community, how can we assure high levels of vaccination/immunity against vaccine preventable diseases in the U.S. and other wealthy countries?

Art Reingold, MD, is Professor and Head of Epidemiology at the UC Berkeley School of Public Health and is the Associate Faculty Director of the UC Berkeley Center for Global Public Health.  Dr. Reingold’s research interests and expertise include prevention of transmission of HIV in developing countries, the intersection of the HIV/AIDS and tuberculosis epidemics, malaria in Uganda, emerging and re-emerging infections in the US and globally, sexual transmission of hepatitis C virus, vaccine-preventable diseases, and respiratory infections in childhood.  Dr. Reingold is a member the Institute of Medicine (IOM) of the National Academy of Science, and serves on the World Health Organization’s Scientific Advisory Group of Experts (SAGE), a committee that advises on all key vaccine-related matters.

Tuesday, March 24th, 2015

CAPS Town Hall Presents Dr. Elvin Geng (12:00 – 1:00 pm)

Dr. Elvin Geng is trained in infectious diseases (MD, Columbia 2002) and epidemiology (MPH, Columbia 2002). His research seeks to apply perspectives from implementation and dissemination sciences to understand the effectiveness of global antiretroviral treatment (ART) programs for HIV-infected patients. Currently, the Global Fund, US President’s Emergency Fund for AIDS Relief (PEPFAR) and national governments have invested billions of dollars for AIDS programs and started five million persons on ART in resource limited settings. Yet the best strategies for engagement in care and treatment with life-long, complicated and potentially toxic medications include many unanswered questions. For patients who present to care, failure to initiate ART is under appreciated and a major barrier that is poorly understood. Once on ART, early mortality – likely to due to ascertained opportunistic infections – is high and the causes incompletely understood. Among patients who stabilize on ART, loss to follow-up is ubiquitous in African ART programs. To address these problems Dr. Geng is involved in a number of studies including (1) assembly of a cohort of HIV-infected patients in southwestern Uganda as part of an NIH funded consortium in East Africa; (2) a nested case control study to identify causes of early mortality in Uganda; (3) extending novel methods into the cohort setting to study engagement in care and (4) and using causal methods to understand longitudinal treatment effects in data collected in these settings.

Dr. Geng hopes to bring clinical contextual knowledge to bear on analysis of data from “real world” settings to improve the effectiveness of global ART implementation, yielding generalizable lessons for science of implementation in health care that may be of use in other settings and other disease conditions.